The Impact of Nursing and Pharmacy Care Between Xeloda and 5-Fluoruracil Regimens in the Management of Colorectal Cancer (CRC) in Hong Kong
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from recruiting to discontinued.
- 11 Feb 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2013 to 1 Dec 2014.
- 06 Mar 2013 New trial record